BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $105.3 million in its fourth quarter.
The Burnaby, British Columbia-based company said it had a loss of $1.31 per share.
The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.20 per share.
For the year, the company reported a loss of $345.9 million, or $4.36 per share. Revenue was reported as $7.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at https://www.zacks.com/ap/XENE
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
